Evidence map›Paper›PMID 34851542›Full record

ReviewJournal of clinical laboratory analysis2022

Bacteriocins: Properties and potential use as antimicrobials.

Atieh Darbandi, Arezoo Asadi, Marzieh Mahdizade Ari, Elnaz Ohadi, Malihe Talebi, Masoume Halaj Zadeh, Amir Darb Emamie, Roya Ghanavati, Maryam Kakanj

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical laboratory analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 195 papers.

0numbers the graph read from it
0cells of the map it votes in
195citing papers in PubMed
39.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

195 citing papers in PubMed, 422 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

135 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Atieh DarbandiDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Arezoo AsadiDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Marzieh Mahdizade AriDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Elnaz OhadiDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Malihe TalebiDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Masoume Halaj ZadehDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Amir Darb EmamieDepartment of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Roya GhanavatiBehbahan Faculty of Medical Sciences, Behbahan, Iran.ORCID https://orcid.org/0000-0002-3851-0001
Maryam KakanjFood and Drug Laboratory Research Center, Food and Drug Administration, MOH&ME, Tehran, Iran.
Iran University of Medical Sciences · IRMinistry of Health and Medical Education · IRTehran University of Medical Sciences · IR

Funding

Behbahan Faculty of medical sciences 99052
6 · The paper itself

Abstract

A variety of bacteriocins originate from lactic acid bacteria, which have recently been modified by scientists. Many strains of lactic acid bacteria related to food groups could produce bacteriocins or antibacterial proteins highly effective against foodborne pathogens such as Staphylococcus aureus, Pseudomonas fluorescens, P. aeruginosa, Salmonella typhi, Shigella flexneri, Listeria monocytogenes, Escherichia coli O157:H7, and Clostridium botulinum. A wide range of bacteria belonging primarily to the genera Bifidobacterium and Lactobacillus have been characterized with different health-promoting attributes. Extensive studies and in-depth understanding of these antimicrobials mechanisms of action could enable scientists to determine their production in specific probiotic lactic acid bacteria, as they are potentially crucial for the final preservation of functional foods or for medicinal applications. In this review study, the structure, classification, mode of operation, safety, and antibacterial properties of bacteriocins as well as their effect on foodborne pathogens and antibiotic-resistant bacteria were extensively studied.

Indexed as

Anti-Bacterial AgentsBacteriaBacteriocinsAnimalsFoodborne DiseasesGastrointestinal MicrobiomeHumansLactobacillalesMiceAnti-Bacterial AgentsBacteriocinsbacteriocinfoodborne pathogenslactic acid bacteria

Identifiers

PMID34851542
PMCPMC8761470
OpenAlexW3217475918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.